Search
TPL
LOGINSUBSCRIBE
Ivermectin can kill COVID-19 within 48 hours, Monash University study finds
21-04-2020 Print
A collaborative study led by Australias Monash Biomedicine Discovery Institute (BDI) with the Peter
To continue reading The Pharma Letter please login, subscribe or claim a 7 day free trial subscription and access exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space.
Or, if you're only interested in reading the content about a specific topic (M&A, coronavirus/COVID-19, pricing, reimbursement and access, outsourcing, CRO and CMO, and regulation), then you can take our 10 per month channel subscription offer, which gives you access to all our news articles and in-depth content on this subject.
Anti-viralsAustraliaCoronavirusFocus OnIvermectinKylie WagstaffMerck & CoPharmaceuticalResearchStromectil
TAKE A FREE TRIAL
WHAT YOU GET
Access The Pharma Letter's latest news free for 7 days
PLUS... you can receive the Pharma Letter headlines and news roundup email free forever
CLICK HERE TO TAKE A FREE TRIAL
BECOME A SUBSCRIBER
WHAT YOU GET
Unlimited access to The Pharma Letter site for a whole year
Only 77 per month or 820 per year
OR 10 PER MONTH FOR ALL CONTENT ON CERTAIN TOPICS
No-limits access to our site with up-to-the minute news Personalised news and email alerts Online discussion forums and Q&A section RSS news feeds that you can add to your favourite reader, or website Daily news email alert, with the breaking news stories and news roundup
CLICK HERE TO SUBSCRIBE
Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It's part of the key information for keeping me informed
Nigel Brooksby, Chairman, Sanofi aventis UK Ltd
LINKS
ABOUT US
SUBSCRIBE
WORK WITH US
CONTACT US
TERMS AND CONDITIONS
PRIVACY POLICY
DRUGS
RSS
PR NEWSWIRE PRESS RELEASES
SPONSORSHIP/ADVERTISING
OUR MISSION
The Pharma Letter provides subscribers with daily, up-to-date news, business intelligence, comment and analysis for the pharmaceutical, biotechnology and generics sectors of the health care industry, backed by a team of respected writers with many years of experience in the field.
CONTACT US
The Pharma Letter
39 to 43 Putney High Street
Putney
London
SW15 1SP
For trial and subscription enquiries please email
[email protected][/email]
For editorial enquiries, press releases and events please email
[email protected]
For all other queries please email [email]
[email protected]
Agile web development by Byte9